• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 在前列腺癌中的作用:从生物发生到应用潜力。

MicroRNA in prostate cancer: from biogenesis to applicative potential.

机构信息

Department of Urology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, 610041, P.R. China.

Department of Urology, West China Tianfu Hospital, Sichuan University, Chengdu, 610213, P.R. China.

出版信息

BMC Urol. 2024 Nov 6;24(1):244. doi: 10.1186/s12894-024-01634-1.

DOI:10.1186/s12894-024-01634-1
PMID:39506720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11539483/
Abstract

Prostate cancer is the most common solid malignant tumor in men, characterized by high morbidity and mortality. While current screening tools, such as prostate-specific antigen (PSA) testing and digital rectal examination, are available for early detection of prostate cancer, their sensitivity and specificity are limited. Tissue puncture biopsy, although capable of offering a definitive diagnosis, has poor positive predictive rates and burdens the patient more. Therefore, more reliable molecular diagnostic tools for prostate cancer urgently need to be developed. In recent years, microRNAs (miRNAs) have attracted much attention in prostate cancer research. miRNAs are extensively engaged in biological processes such as cell proliferation, differentiation, apoptosis, migration, and invasion by modulating gene expression post-transcriptionally. Dysregulation of miRNA expression in cancer is considered a critical factor in tumorigenesis and progression. This review first briefly introduces the biogenesis of miRNAs and their functions in cancer, then focuses on tumor-promoting miRNAs and tumor-suppressor miRNAs in prostate cancer. Finally, the potential application of miRNAs as multifunctional tools for cancer diagnosis, prognostic assessment, and therapy is discussed in detail. The concluding section summarizes the major points of the review and the challenges ahead.

摘要

前列腺癌是男性最常见的实体恶性肿瘤,其发病率和死亡率都很高。目前已有前列腺特异性抗原(PSA)检测和直肠指检等筛查工具可用于早期发现前列腺癌,但它们的灵敏度和特异性有限。组织穿刺活检虽然能够提供明确的诊断,但阳性预测率较差,且给患者带来更多的负担。因此,迫切需要开发更可靠的前列腺癌分子诊断工具。近年来,microRNAs(miRNAs)在前列腺癌研究中受到了广泛关注。miRNAs 通过转录后调控基因表达,广泛参与细胞增殖、分化、凋亡、迁移和侵袭等生物学过程。癌症中 miRNA 表达的失调被认为是肿瘤发生和进展的关键因素。本文首先简要介绍了 miRNAs 的生物发生及其在癌症中的功能,然后重点介绍了前列腺癌中的促瘤 miRNA 和抑瘤 miRNA。最后,详细讨论了 miRNAs 作为癌症诊断、预后评估和治疗多功能工具的潜在应用。结论部分总结了综述的要点和未来的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df11/11539483/87b2d615d974/12894_2024_1634_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df11/11539483/87b2d615d974/12894_2024_1634_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df11/11539483/87b2d615d974/12894_2024_1634_Fig1_HTML.jpg

相似文献

1
MicroRNA in prostate cancer: from biogenesis to applicative potential.微小 RNA 在前列腺癌中的作用:从生物发生到应用潜力。
BMC Urol. 2024 Nov 6;24(1):244. doi: 10.1186/s12894-024-01634-1.
2
Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.游离微小RNA在前列腺癌中的诊断、预后及预测价值:一项系统综述
Mol Cancer. 2016 May 18;15(1):41. doi: 10.1186/s12943-016-0523-5.
3
Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer.miRNA-145、148 和 185 及干细胞在前列腺癌中的作用。
Int J Mol Sci. 2022 Jan 30;23(3):1626. doi: 10.3390/ijms23031626.
4
Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.微小 RNA 在结直肠癌中的分子功能:在增殖、血管生成、凋亡和化疗耐药性中的最新作用。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5617-5630. doi: 10.1007/s00210-024-03076-w. Epub 2024 Apr 15.
5
MicroRNAs in prostate cancer: From function to biomarker discovery.前列腺癌中的 microRNAs:从功能到生物标志物发现。
Exp Biol Med (Maywood). 2018 Jun;243(10):817-825. doi: 10.1177/1535370218775657.
6
The role of miRNA in prostate cancer diagnosis, prognosis and treatment response: a narrative review.微小RNA在前列腺癌诊断、预后及治疗反应中的作用:一项叙述性综述
Future Oncol. 2023 Jan;19(1):77-93. doi: 10.2217/fon-2022-0891. Epub 2023 Jan 27.
7
Circulating miRNAs 21 and 221 as biomarkers for early diagnosis of prostate cancer.循环miRNAs 21和221作为前列腺癌早期诊断的生物标志物。
Tumour Biol. 2014 Dec;35(12):12613-7. doi: 10.1007/s13277-014-2584-7. Epub 2014 Sep 5.
8
MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer.微小RNA作为前列腺癌早期诊断、靶向治疗和预后的生物标志物
Pathol Res Pract. 2023 Aug;248:154618. doi: 10.1016/j.prp.2023.154618. Epub 2023 Jun 13.
9
The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.微小 RNA 特征:前列腺癌中异常表达的微小 RNA。
Clin Transl Oncol. 2019 Feb;21(2):126-144. doi: 10.1007/s12094-018-1910-8. Epub 2018 Jun 27.
10
miRNAs as biomarkers in prostate cancer.miRNAs 作为前列腺癌的生物标志物。
Clin Transl Oncol. 2012 Nov;14(11):803-11. doi: 10.1007/s12094-012-0877-0. Epub 2012 Jul 24.

引用本文的文献

1
MiR-135a-3p inhibits the progression of prostate cancer by targeting TLR4.微小RNA-135a-3p通过靶向Toll样受体4抑制前列腺癌进展。
Cancer Biol Ther. 2025 Dec;26(1):2545653. doi: 10.1080/15384047.2025.2545653. Epub 2025 Aug 22.
2
Overdiagnosis and Overtreatment in Prostate Cancer.前列腺癌的过度诊断与过度治疗
Diseases. 2025 May 24;13(6):167. doi: 10.3390/diseases13060167.

本文引用的文献

1
Prostate cancer and the cell cycle: Focusing on the role of microRNAs.前列腺癌与细胞周期:聚焦于 microRNAs 的作用。
Gene. 2024 Nov 30;928:148785. doi: 10.1016/j.gene.2024.148785. Epub 2024 Jul 23.
2
Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement.前列腺特异性抗原筛查前列腺癌:诊断性能、临床阈值和优化策略。
Urol Oncol. 2025 Jan;43(1):41-48. doi: 10.1016/j.urolonc.2024.06.003. Epub 2024 Jul 17.
3
A systematic review of family history, race/ethnicity, and genetic risk on prostate cancer detection and outcomes: Considerations in PSA-based screening.
基于 PSA 的筛查:家族史、种族/民族和遗传风险对前列腺癌检测和结果的系统评价中的考虑因素。
Urol Oncol. 2025 Jan;43(1):29-40. doi: 10.1016/j.urolonc.2024.06.002. Epub 2024 Jul 15.
4
Early Prostate Cancer Deaths Among Men With Higher vs Lower Genetic Risk.具有较高遗传风险与较低遗传风险的男性中前列腺癌早期死亡的比较。
JAMA Netw Open. 2024 Jul 1;7(7):e2420034. doi: 10.1001/jamanetworkopen.2024.20034.
5
Circular RNAs in Cell Cycle Regulation of Cancers.环状 RNA 在癌症细胞周期调控中的作用。
Int J Mol Sci. 2024 May 31;25(11):6094. doi: 10.3390/ijms25116094.
6
MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances.MicroRNAs:通过生物传感器和机器学习的进步,作为用于早期检测难以察觉的癌症的循环生物标志物。
Oncogene. 2024 Jul;43(28):2135-2142. doi: 10.1038/s41388-024-03076-3. Epub 2024 Jun 5.
7
The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men.影响非裔美国男性前列腺癌差异的可改变风险因素的复杂相互作用。
Nat Rev Urol. 2024 Jul;21(7):422-432. doi: 10.1038/s41585-023-00849-5. Epub 2024 Feb 2.
8
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.结直肠癌干细胞与免疫细胞在肿瘤发生中的相互作用以及靶向结直肠癌干细胞的策略。
Exp Hematol Oncol. 2024 Jan 22;13(1):6. doi: 10.1186/s40164-024-00474-x.
9
Diagnostic and Prognostic Value of miR-93 in Prostate Cancer: A Meta-Analysis and Bioinformatics Analysis.miR-93在前列腺癌中的诊断和预后价值:一项荟萃分析和生物信息学分析
Iran J Public Health. 2023 Nov;52(11):2260-2271. doi: 10.18502/ijph.v52i11.14026.
10
miRNA Expression Patterns in Early- and Late-Stage Prostate Cancer Patients: High-Throughput Analysis.早期和晚期前列腺癌患者的miRNA表达模式:高通量分析
Biomedicines. 2023 Nov 16;11(11):3073. doi: 10.3390/biomedicines11113073.